SCHEMBL21348350

SCHEMBL21348350

c1cc(-c2onc3ccccc23)c2n[nH]cc2c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.33
▸ HPGD P15428 4/20 0.33
▸ SMN1; SMN2 Q16637 4/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ MAPT P10636 3/20 0.33
▸ MAPK1 P28482 3/20 0.33
▸ HSD17B10 Q99714 3/20 0.33
▸ TP53 P04637 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ C1R P00736 2/20 0.32
▸ PARP1 P09874 1/20 0.32
▸ NPC1 O15118 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21473854 0.81 — —
SCHEMBL31040367 0.73 IDO1 (0.37) ALDH1A1HPGDSMN1; SMN2KDM4EMAPT
SCHEMBL31001160 0.70 ALDH1A1 (0.46) ALDH1A1HPGDSMN1; SMN2KDM4EMAPT
SCHEMBL20622955 0.68 IMPDH2 (0.35) ALDH1A1HPGDSMN1; SMN2KDM4EMAPT
SCHEMBL5201632 0.67 ALDH1A1 (0.46) ALDH1A1HPGDSMN1; SMN2KDM4EMAPT
SCHEMBL6691319 0.65 ALDH1A1 (0.55) ALDH1A1HPGDSMN1; SMN2KDM4EMAPT
SCHEMBL10396387 0.65 ELANE (0.35) ALDH1A1HPGDSMN1; SMN2KDM4EMAPT
SCHEMBL2492556 0.63 ALDH1A1 (0.62) ALDH1A1HPGDSMN1; SMN2KDM4EMAPT
SCHEMBL28352680 0.63 ADORA2A (0.42) ALDH1A1HPGDSMN1; SMN2KDM4EMAPT
SCHEMBL10598338 0.62 CYP1A2 (0.37) ALDH1A1HPGDSMN1; SMN2KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230363270-A1 ORGANIC COMPOUNDS, ORGANIC MIXTURES AND THE USES THEREOF Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-09 — — US disclosed
US-20200185615-A1 ORGANIC CHEMICAL COMPOUND, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC COMPONENT GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) 2020-06-11 — — US disclosed
US-20190276696-A1 FORMULATIONS FOR PRINTED ELECTRONIC DEVICES, PREPARATION METHODS AND USES THEREOF GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) 2019-09-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230363270-A1 ORGANIC COMPOUNDS, ORGANIC MIXTURES AND THE USES THEREOF AOX1, ODC1, OTC ALDH1A1 130/4885HPGD 1613/4885SMN1; SMN2 4306/4885
US-20200185615-A1 ORGANIC CHEMICAL COMPOUND, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC COMPONENT OSTC, ODC1, ORC3 ALDH1A1 216/4885HPGD 3631/4885SMN1; SMN2 4207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback